(1) calcium benzenesulfonate raw material has been completed process validation work, ready to declare production approval and GMP certification, azazepine, glimepiride and repaglinide three API products are currently completed Try to explore;

(2) sitafloxacin APIs and tablets are now in the clinical stage and are looking for suitable clinical trials to cooperate;

(3) the United States Aosta three products currently progressing smoothly, which Solinar new film has been declared clinical, Fenghomodine hydrochloride capsules and sitagliptin metformin tablets have also been completed pilot production;

(4) Fudan University statin products under the guidance of Academician Chen Feni has completed some of the key small-scale process steps to explore.